Interleukin-2 inhibits NMDA receptor-mediated currents directly and may differentially affect subtypes

Biochem Biophys Res Commun. 2006 Dec 15;351(2):449-54. doi: 10.1016/j.bbrc.2006.10.047. Epub 2006 Oct 17.

Abstract

Using whole-cell patch-clamp recordings, this study investigated the effects of interleukin-2 (IL-2) on N-methyl-d-aspartate (NMDA) receptor-mediated currents (I(NMDA)) in rat cultured hippocampal neurons and human embryonic kidney (HEK) 293 cells expressing recombinant NMDA receptors. We found that IL-2 (0.01-1ng/ml) immediately and significantly decreased peak I(NMDA) in cultured neurons. Interestingly, the peak I(NMDA) induced in HEK 293 cells was also inhibited by IL-2. We also found that IL-2 differentially decreased the peak amplitudes of NR2A- and NR2B-containing NMDA receptor-mediated currents (I(NR2A) and I(NR2B)) by 54+/-5% and 30+/-4%, respectively. These results provide new evidence that IL-2 induces rapid inhibition of peak currents of NMDA receptor-mediated responses with possible NR1/NR2A and NR1/NR2B subtype-differentiation, and suggest that the inhibition is mediated by direct interaction between IL-2 and NMDA receptors.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cloning, Molecular
  • Hippocampus / cytology
  • Humans
  • Interleukin-2 / pharmacology
  • Interleukin-2 / physiology*
  • Ion Channel Gating
  • Neurons / drug effects
  • Neurons / physiology*
  • Patch-Clamp Techniques
  • Protein Isoforms / genetics
  • Protein Isoforms / physiology
  • Rats
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / physiology*

Substances

  • Interleukin-2
  • NR2A NMDA receptor
  • NR2B NMDA receptor
  • Protein Isoforms
  • Receptors, N-Methyl-D-Aspartate